IRIS
MUCCINI, CAMILLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.821
NA - Nord America 1.387
AS - Asia 1.369
SA - Sud America 233
AF - Africa 63
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.888
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.318
RU - Federazione Russa 1.066
CN - Cina 447
SG - Singapore 441
IT - Italia 244
BR - Brasile 185
HK - Hong Kong 126
VN - Vietnam 126
DE - Germania 119
SE - Svezia 115
GB - Regno Unito 66
FR - Francia 63
BD - Bangladesh 49
CA - Canada 41
FI - Finlandia 40
IN - India 34
JP - Giappone 23
ZA - Sudafrica 22
PL - Polonia 20
ES - Italia 19
AT - Austria 17
MX - Messico 16
AR - Argentina 15
TR - Turchia 15
NL - Olanda 14
AU - Australia 13
IQ - Iraq 13
AE - Emirati Arabi Uniti 12
ID - Indonesia 12
LT - Lituania 12
PK - Pakistan 12
NG - Nigeria 10
PH - Filippine 9
VE - Venezuela 8
BE - Belgio 7
EC - Ecuador 7
TN - Tunisia 7
CH - Svizzera 6
GH - Ghana 6
PE - Perù 6
CO - Colombia 5
MY - Malesia 5
SA - Arabia Saudita 5
UZ - Uzbekistan 5
CL - Cile 4
IR - Iran 4
PS - Palestinian Territory 4
CY - Cipro 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
KE - Kenya 3
MA - Marocco 3
MD - Moldavia 3
OM - Oman 3
TH - Thailandia 3
AZ - Azerbaigian 2
BH - Bahrain 2
HN - Honduras 2
IE - Irlanda 2
IL - Israele 2
JO - Giordania 2
KR - Corea 2
MZ - Mozambico 2
NP - Nepal 2
SV - El Salvador 2
TZ - Tanzania 2
UG - Uganda 2
UY - Uruguay 2
AL - Albania 1
AM - Armenia 1
BB - Barbados 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
EU - Europa 1
GR - Grecia 1
GT - Guatemala 1
HR - Croazia 1
JM - Giamaica 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
MT - Malta 1
NI - Nicaragua 1
PA - Panama 1
RO - Romania 1
SY - Repubblica araba siriana 1
TV - Tuvalu 1
UA - Ucraina 1
Totale 4.888
Salva come PNG Salva come JPEG
Città #
Singapore 256
Ashburn 201
Moscow 192
Dallas 184
San Jose 153
Hong Kong 122
New York 114
Shanghai 92
Beijing 73
Munich 54
Ho Chi Minh City 52
Hefei 49
Lauterbourg 44
Milan 43
Los Angeles 42
Rome 35
Orem 34
Boardman 33
Hanoi 33
Helsinki 27
São Paulo 25
Denver 23
Nuremberg 23
Lawrence 22
Princeton 22
Tokyo 22
Warsaw 20
Council Bluffs 19
Montreal 19
Houston 17
Poplar 16
Johannesburg 15
London 15
Santa Clara 15
Atlanta 14
Chennai 13
Frankfurt am Main 12
Washington 11
Brooklyn 10
Chicago 10
Guangzhou 10
Phoenix 10
Manchester 9
Seattle 9
Toronto 9
Ankara 8
Boston 8
Pietra Ligure 8
Rio de Janeiro 8
Stockholm 8
Vienna 8
Falkenstein 7
Sharjah 7
Accra 6
Amsterdam 6
Baghdad 6
Barnet 6
Belo Horizonte 6
Cesano Boscone 6
Da Nang 6
Lagos 6
Melbourne 6
Mexico City 6
New Delhi 6
Omaha 6
Shenzhen 6
Turku 6
Brussels 5
Hangzhou 5
Lahore 5
Lappeenranta 5
Quezon City 5
San Francisco 5
Vittoria 5
Catania 4
Columbus 4
Hải Dương 4
Karachi 4
Las Vegas 4
Lima 4
Madrid 4
Monsummano Terme 4
Ottawa 4
Pune 4
Romagnano Sesia 4
St Louis 4
Sydney 4
Tashkent 4
Vauderens 4
Angera 3
Basra 3
Buenos Aires 3
Buffalo 3
Cambridge 3
Charlotte 3
Chisinau 3
City of London 3
Curitiba 3
Dubai 3
Haiphong 3
Totale 2.497
Salva come PNG Salva come JPEG
Nome #
Evaluation of HIV reservoir in specific populations: people with a multi-drug resistant virus or a viral coinfection 298
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors 206
Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 177
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 168
Candidemia in COVID-19 patients: incidence and characteristics in a prospective cohort compared to historical non-COVID-19 controls 145
Meningococcus B Vaccination Effectiveness Against Neisseria gonorrhoeae Infection in People Living With HIV: A Case-Control Study 141
A case of breakthrough mpox infection in an individual non-responder to MVA-BN vaccination 132
Publisher Correction: Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 (Scientific Reports, (2020), 10, 1, (21291), 10.1038/s41598-020-78039-1) 125
Analysis of the faecal microbiome during analytical treatment interruption in people with chronic HIV infection and long-lasting virological suppression (APACHE study) 114
Analytical treatment interruption in chronic HIV-1 infection: Time and magnitude of viral rebound in adults with 10 years of undetectable viral load and low HIV-DNA (APACHE study) 113
Treatment success of rescue regimens after dual therapy failure in people living with HIV in a real-life setting 113
Association of high-risk sexual behaviours with sexually transmitted infections among men who have sex with men living with HIV 111
Dynamics of HIV-1 POL antibodies after ART in chronic HIV-1 infection 111
Achieving virological control in pan-resistant HIV-1 infection: A case series 110
Risk of Cardiovascular Diseases or Mortality in People with Higher Values of HIV-1 DNA 109
SARS-CoV-2 IgG/IgM Rapid Test as a Diagnostic Tool in Hospitalized Patients and Healthcare Workers, at a large Teaching Hospital in northern Italy, during the 2020 COVID-19 Pandemic 108
Serum IgG1 and IgG4 could contribute to partial control of viral rebound in chronically HIV-1-infected patients 105
Changes in homeostatic model assessment for insulin resistance (HOMA-IR) index in treated HIV-1 infected people on virological suppression who switched to a different antiretroviral regimen 104
Brief Report: Association Between Low HIV-1 DNA and Western Blot Reactivity to HIV-1 Pol in Chronically Infected Individuals 103
One Year of Long-Acting Cabotegravir and Rilpivirine in People With Human Immunodeficiency Virus and Long Exposure to Antiretroviral Therapy: Data From the SCohoLART Study 100
A four-drug combination oral tablet of darunavir, cobicistat, emtricitabine, and tenofovir alafenamide for the treatment of HIV-1 infection in adults 98
Impact of predicted HLA class I immunopeptidome on viral reservoir in a cohort of people living with HIV in Italy 97
Challenging management of a post-coronavirus disease 2019 invasive Aspergillus sinusitis in a person living with HIV 95
Two-fold increased risk of cardiovascular events in people with MDR HIV: a matched cohort analysis with data from the PRESTIGIO registry 93
Increasing incidence and prevalence of metabolic syndrome in people living with HIV during the COVID-19 pandemic 91
Efficacy and Safety Profile of Fostemsavir for the Treatment of People with Human Immunodeficiency Virus-1 (HIV-1): Current Evidence and Place in Therapy 91
Associations between integrase strand-transfer inhibitors and cardiovascular disease in people living with HIV: a multicentre prospective study from the RESPOND cohort consortium 90
Association between low levels of HIV-1 DNA and HLA class I molecules in chronic HIV-1 infection 90
Increasing trend of transmitted integrase inhibitor resistance in a cohort of antiretroviral therapy-naive people living with HIV 87
Doravirine associated with greater LDL cholesterol reduction in people with HIV switching antiretroviral regimens 86
Should we expect weight changes in people with HIV and a reported weight gain only by switching antiretroviral therapy? 85
Outcomes after a virological failure to first-line second-generation INSTI-based therapy in a real-life setting 85
Cancer incidence in people with HIV in Italy: Comparison of the ICONA COHORT with general population data 83
Anti-HIV antibodies are representative of the latent reservoir but do not correlate with viral control in people with long-lasting virological suppression undergoing analytical treatment interruption (APACHE study) 83
Retrospective study on the outcome of two-drug regimens based on dolutegravir plus one reverse transcriptase inhibitor in virologically-suppressed HIV-infected patients 82
All-Cause Mortality in People With Four-Class Drug-Resistant Human Immunodeficiency Virus: A Matched Cohort Analysis With Data From the PRESTIGIO Registry 81
Contemporary antiretrovirals and body-mass index: a prospective study of the RESPOND cohort consortium 81
Cerebrospinal fluid viral replication and burden of resistance in three HIV-1-infected people taking Ibalizumab with multiple drug class-wide resistance 75
Western blot in treated people with HIV-1 chronic infection: frequency of negative HIV-1 pol genes 75
Subclinical atherosclerosis as detected by carotid ultrasound and associations with cardiac and HIV-specific risk factors; the Archi-Prevaleat project 68
Residual viremia in HIV-infected patients who continue a two-drug or switch to a three-drug integrase strand transfer inhibitor based regimen 67
Incidence of dyslipidemia in people with HIV who are treated with integrase inhibitors versus other antiretroviral agents 64
Homeostatic model assessment for insulin resistance index trajectories in HIV-infected patients treated with different first-line antiretroviral regimens 60
HIV Pol: does it offer therapeutic targets for HIV? 59
Exercise ECG for coronary artery disease screening in people living with HIV: The cordis STUDY 59
Recent abacavir use and incident cardiovascular disease in contemporary-treated people with HIV 58
Persistence of CXCR4-tropic virus in people living with four-class drug-resistant HIV and its clinical impact in the modern antiretroviral era 56
Immune activation, inflammation and HIV DNA after 96 weeks of ATV/r monotherapy: A MODAt substudy 52
Integrase Strand Transfer Inhibitor Use and Cancer Incidence in a Large Cohort Setting 48
People with four-class drug-resistant HIV-1 may have low levels of intact DNA 46
Pharmacokinetic evaluation of bictegravir + emtricitabine + tenofovir alafenamide in HIV treatment 23
Bictegravir/Emtricitabine/Tenofovir Alafenamide Treatment: Efficacy and Tolerability in Clinical Practice 13
HIV cure-related research: where we stand and where we go 4
Safety, Tolerability, and Metabolic Effects of Long-Acting Cabotegravir and Rilpivirine in HIV Care: A Comprehensive Review 3
Cardiometabolic complications in children and adolescents with HIV on antiretroviral therapy 2
Improvement in high-density lipoprotein cholesterol in people with HIV who switched from a tenofovir alafenamide-containing regimen to cabotegravir plus rilpivirine 2
User-reported outcomes of long-acting injectable PrEP with Cabotegravir: Real-world experience from Milan 1
Highlighting advances on clinical management of pediatric HIV 1
Evaluating long-acting injectable HIV treatment: an update on cabotegravir and rilpivirine 1
Time to HIV viral rebound and frequency of post-treatment control after analytical interruption of antiretroviral therapy: an individual data-based meta-analysis of 24 prospective studies 1
A neural-network approach for predicting time to cardiovascular diseases in HIV patients based on real-world data 1
Are glucagon-like peptide 1 receptor agonists effective in decreasing body weight and body mass index in people living with diabetes and HIV? 1
Totale 5.031
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.169
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.169
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202249 0 0 0 8 1 6 4 10 8 3 2 7
2022/2023202 52 44 11 3 8 18 25 22 5 2 6 6
2023/2024428 14 16 79 30 49 71 41 38 3 16 15 56
2024/2025877 66 28 19 33 79 90 120 109 90 49 59 135
2025/20263.454 245 187 220 388 313 129 282 292 927 212 180 79
Totale 5.031